Geode Capital Management’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Geode Capital Management’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-580,941	Closed	-$2.85M	–	4647
2024 Q1	$2.85M	Buy	580,941 +49,665	+9%	+$236K	﹤0.01%	2971
2023 Q4	$1.94M	Buy	531,276 +59,990	+13%	+$164K	﹤0.01%	3110
2023 Q3	$1.05M	Buy	471,286 +3,571	+0.8%	+$9.97K	﹤0.01%	3298
2023 Q2	$1.59M	Buy	467,715 +74,090	+19%	+$267K	﹤0.01%	3183
2023 Q1	$1.57M	Buy	393,625 +3,071	+0.8%	+$13.5K	﹤0.01%	3132
2022 Q4	$2.12M	Buy	390,554 +44,648	+13%	+$263K	﹤0.01%	3010
2022 Q3	$1.74M	Buy	345,906 +33,090	+11%	+$163K	﹤0.01%	3132
2022 Q2	$1.19M	Buy	+312,816	New	+$2M	﹤0.01%	3346

Geode Capital Management's TGAN Position: Q2 2024 in Review

Geode Capital Management sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 580,941 shares — an estimated $2.85M sold.

Geode Capital Management first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $2.85M in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Geode Capital Management reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Geode Capital Management sold 580,941 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $2.85M.
Geode Capital Management first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Geode Capital Management's Transphorm, Inc. Common Stock position peaked at $2.85M in Q1 2024.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Geode Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.